Fast Track Diagnostics
Fast Track Diagnostics is a privately held Malta-based global supplier of in-vitro diagnostic tests, founded in 2007 and operating with 51–100 employees from Sliema. The company serves clinical and laboratory customers internationally within the regulated diagnostics sector.
- Company typePrivate
- Founded2007
- HeadquartersSliema, Malta
- Headcount51–100
- GTM typeB2B
- OfferingHardware or Manufacturing
What Fast Track Diagnostics does
Fast Track Diagnostics is a Malta-based, privately held diagnostics company headquartered in Sliema, founded in 2007 and operating with 51–100 employees. The firm self-describes as a global supplier of diagnostics tests, indicating a business model built on distributing diagnostic products to laboratory and clinical customers in international markets rather than a service- or software-only offering. As a private company in a regulated healthcare vertical, it competes within a sector characterized by long product validation cycles, regulatory clearance barriers, and recurring consumable revenue tied to installed instrumentation.
The input product data associated with the company is not internally consistent: the firmographic record points to a Malta-headquartered, mid-sized diagnostics supplier, while the product catalog and marketing language ingested alongside it reference Siemens Healthineers' Laboratory Diagnostics portfolio — including the Atellica Solution/Atellica CI Analyzer, IMMULITE 2000 XPi, ADVIA Chemistry and Centaur systems, Dimension Systems, Atellica HEMA (hematology), CN-3000/CN-6000 (hemostasis), Atellica 1500 (urinalysis), Atellica NEPH (plasma proteins), and Atellica DT 250 (drug testing), together with Atellica Data Manager, Aptio Automation, and epoc NXS point-of-care testing. This catalog also enumerates an assay menu across 20+ disease categories (allergy, anemia, autoimmune, bone metabolism, cardiac, diabetes, drugs of abuse, growth disorders, hemostatic disorders, infectious disease, kidney disease, liver fibrosis, neurology, oncology, transplant, reproductive endocrinology, sepsis & inflammation, TDM, thyroid, veterinary) and references ACT Ecolabel / My Green Lab sustainability certifications. A reasonable reading is that the product data may reflect a parent or affiliate relationship, but the input does not confirm any parent-company linkage, M&A history, or governance tie between FTD and Siemens Healthineers.
What can be stated with confidence from the data: FTD operates in in-vitro diagnostics, targets global laboratory and clinical customers, and is a for-profit private company of modest headcount (51–100) based in Malta. No pricing model, revenue figures, customer logos, management details beyond the CEO (Bill Carman), or geographic revenue mix are disclosed, so the company's specific go-to-market mechanics, channel structure, and financial scale cannot be characterized from the input alone.
Fast Track Diagnostics firmographics
Firmographics- Name
- Fast Track Diagnostics
- Website
- https://fast-trackdiagnostics.com
- Company type
- Private
- Founded year
- 2007
- Headcount range
- 51–100 employees
- Short description
- Fast Track Diagnostics is a privately held Malta-based global supplier of in-vitro diagnostic tests, founded in 2007 and operating with 51–100 employees from Sliema. The company serves clinical and laboratory customers internationally within the regulated diagnostics sector.
- Ownership category
- akta.pro rank
Fast Track Diagnostics industry classification
Industry- Product category
- In Vitro Diagnostics
- NAICS
- In-Vitro Diagnostic Substance Manufacturing (325413)
- SIC
- In Vitro & In Vivo Diagnostic Substances (2835)
- akta.pro primary industry
- IVD Reagents, Assay Kits & Consumables (Non-instrument) (HLAHAAAM)
Keywords
Where Fast Track Diagnostics is headquartered
LocationHeadquarters
- HQ city
- Sliema
- HQ country
- Malta
- HQ region
- Europe
Markets served
Fast Track Diagnostics business model
Business model- GTM type
- B2B
- Offering type
- Hardware or Manufacturing
- Cost components
- Technology or R&D, Supply Chain, Personnel, Operations, Marketing or Sales, Infrastructure
Fast Track Diagnostics product offering
Product offeringCore offering
Fast Track Diagnostics supplies a comprehensive portfolio of automated in vitro diagnostic systems, assay reagents, and laboratory automation solutions for clinical laboratories. The offering spans clinical chemistry and immunoassay analyzers (Atellica, IMMULITE, ADVIA, Dimension families), specialty testing systems (hematology, hemostasis, urinalysis, plasma proteins, drug testing), diagnostics IT software, and point-of-care testing devices. The product range is supported by an assay menu covering over 20 disease categories including infectious disease, cardiac, oncology, thyroid, and therapeutic drug monitoring.
Product overview
Fast Track Diagnostics (Siemens Healthineers Laboratory Diagnostics) offers a comprehensive, platform-based portfolio of automated in vitro diagnostic systems and assay menus. The core product lines include the Atellica Solution and Atellica CI Analyzer families (clinical chemistry and immunoassay systems), the IMMULITE 2000 XPi immunoassay system, ADVIA Chemistry Systems, ADVIA Centaur Systems, and Dimension Systems. These analyzer platforms are complemented by specialized testing lines: Atellica HEMA (hematology), CN-3000/CN-6000 (hemostasis), Atellica 1500 (urinalysis), Atellica NEPH (plasma proteins), and Atellica DT 250 (drug testing). Supporting the analyzer ecosystem are Atellica Data Manager (diagnostics IT), Lab Automation (Aptio Multidisciplinary Track), and a point-of-care testing portfolio (epoc NXS). The portfolio spans over 20 assay disease categories — including allergy, cardiac, infectious disease, oncology, therapeutic drug monitoring, and more — that run on these dedicated analyzer platforms. The overarching design philosophy automates routine laboratory work to reduce manual burden on staff, enabling more time for clinical decision-making.
Differentiator
Problem solved
Functional benefit
Products and services
- Atellica Solution A multidisciplinary clinical chemistry and immunoassay analyzer system designed to automate routine laboratory testing workflows and reduce manual work for laboratory staff.
- Atellica CI Analyzer A clinical chemistry and immunoassay analyzer within the Atellica family, supporting a broad assay menu for diagnostic testing.
- IMMULITE 2000 XPi System An immunoassay system designed for automated, high-throughput testing across a wide range of diagnostic assay menus.
- ADVIA Chemistry Systems A family of clinical chemistry analyzer systems delivering automated diagnostic testing for various laboratory needs.
- ADVIA Centaur Systems Immunoassay analyzer systems providing automated testing across broad assay menus for clinical diagnostics.
- Dimension Systems Integrated chemistry systems designed for automated diagnostic testing within laboratory environments.
- Atellica Data Manager Diagnostics IT software for managing and connecting laboratory data across multiple analyzers and testing systems.
- Lab Automation (Aptio Multidisciplinary Track) Automation solutions including the Aptio Multidisciplinary Track for connecting multiple analyzer systems and streamlining laboratory workflows.
- Atellica HEMA Hematology testing solutions for complete blood count and related blood analysis diagnostics.
- CN-3000 and CN-6000 Systems Hemostasis testing systems for coagulation analysis and blood clotting disorder diagnostics.
- Atellica 1500 Point-of-care urinalysis solution for automated urine testing at the bedside or in clinical settings.
- Atellica NEPH Plasma protein testing system for specialized diagnostic assays related to kidney function and plasma protein analysis.
- Atellica DT 250 Drug Testing Analyzer Automated drug testing analyzer for diagnostic applications supporting clinical toxicology workflows.
- Point-of-Care Testing (epoc NXS) Portable point-of-care diagnostic testing solutions including the epoc NXS system for rapid bedside testing.
Companies that use Fast Track Diagnostics
Customer profileIdeal customer profiles1 record
Fast Track Diagnostics technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Fast Track Diagnostics partnerships and signals
Strategic signalRecent moves4 records
Expansion highlights4 records
Fast Track Diagnostics competitors and assessment
Company assessmentDirect peers
- Qiagen: Global supplier of molecular diagnostics kits and sample-preparation reagents, comparable to Fast Track Diagnostics as a focused provider of IVD test consumables used by clinical and reference laboratories.
- Cepheid (Danaher): Provides molecular diagnostic tests and the GeneXpert system used in clinical and reference laboratories. Directly comparable as a diagnostics test supplier serving similar lab customers.
- Seegene: Specialized developer of multiplex molecular diagnostic assays and PCR kits for infectious disease and other indications, closely aligned with FTD's likely focus on IVD test kits.
- ELITech Group: European-headquartered specialty IVD company offering molecular diagnostics kits and clinical chemistry reagents. Closely comparable to FTD by scale, geography, and product focus.
- Bio-Rad Laboratories: Supplies a broad portfolio of IVD reagents, kits, and quality controls to clinical laboratories worldwide. Overlaps directly with Fast Track Diagnostics' positioning as a diagnostics test supplier, though Bio-Rad is materially larger.
- Luminex (DiaSorin): Supplies molecular diagnostic assays and instrumentation (now part of DiaSorin) to clinical laboratories, with comparable product positioning to FTD in molecular IVD test supply.
Broad incumbents
- Roche Diagnostics: World-leading IVD platform provider with broad assay menus and cobas analyzer systems. Competes with FTD in the broader diagnostic test supply market across clinical chemistry, immunoassay, and molecular.
- Hologic: Major diagnostics company with molecular assay menus, Panther systems, and a global commercial footprint. Overlaps with FTD in supplying diagnostic tests to clinical labs but operates at significantly larger scale.
- Abbott Diagnostics: Global diagnostics incumbent offering integrated analyzer-reagent platforms spanning immunoassay, clinical chemistry, and molecular diagnostics. Competes with FTD for hospital and reference lab test budgets.
Emerging players
- GenMark Diagnostics: Developed multiplex molecular diagnostic tests for syndromic respiratory and other panels. Comparable in focus on specialty diagnostic test kits, though now part of Roche.
Market position
Strengths4 records
Weaknesses4 records
Competitive moat5 records
Key risks5 records
Key highlights4 records
Customer concentration
Fast Track Diagnostics social profiles
Digital presenceFast Track Diagnostics financial estimates
Financial estimateRevenue estimate
Valuation estimate
Fast Track Diagnostics leadership team
Management profileNumber of profiles
Profiles1 record
Fast Track Diagnostics funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Fast Track Diagnostics M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Fast Track Diagnostics
What does Fast Track Diagnostics do?
Fast Track Diagnostics supplies a comprehensive portfolio of automated in vitro diagnostic systems, assay reagents, and laboratory automation solutions for clinical laboratories. The offering spans clinical chemistry and immunoassay analyzers (Atellica, IMMULITE, ADVIA, Dimension families), specialty testing systems (hematology, hemostasis, urinalysis, plasma proteins, drug testing), diagnostics IT software, and point-of-care testing devices. The product range is supported by an assay menu covering over 20 disease categories including infectious disease, cardiac, oncology, thyroid, and therapeutic drug monitoring.
When was Fast Track Diagnostics founded?
Fast Track Diagnostics was founded in 2007. It employs 51 to 100 people.
Where is Fast Track Diagnostics based?
Fast Track Diagnostics is headquartered in Sliema, Malta, in the Europe region.
Who are Fast Track Diagnostics's main competitors?
Direct peers on record are Qiagen, Cepheid (Danaher), Seegene, ELITech Group, Bio-Rad Laboratories and Luminex (DiaSorin). Broad incumbents are Roche Diagnostics, Hologic and Abbott Diagnostics. GenMark Diagnostics is listed as an emerging player.
Does Fast Track Diagnostics have an API?
No public API is recorded for Fast Track Diagnostics.
What industry is Fast Track Diagnostics in?
Fast Track Diagnostics's product category is In Vitro Diagnostics. Its primary akta.pro industry code is HLAHAAAM, IVD Reagents, Assay Kits & Consumables (Non-instrument). Its NAICS code is 325413 and its SIC code is 2835.